Drug class
Treatments for Rosacea Erythema
The phrase "Treatments for Rosacea Erythema" is a clinical indication grouping rather than a formal, single pharmacological drug class. Read more about Treatments for Rosacea Erythema
14 drugs in this class 8 manufacturers
Drugs in Treatments for Rosacea Erythema
DAZOMON (brimonidine tartrate)
RHOFADE (oxymetazoline HCl)
RHOFADE (oxymetazoline HCl)
BRIMONIDINE TARTRATE
REMYDA (brimonidine tartrate)
ROVIS (brimonidine tartrate/ivermectin/metronidazole/niacinamide)
BRIMONIDINE TARTRATE
The phrase "Treatments for Rosacea Erythema" is a clinical indication grouping rather than a formal, single pharmacological drug class.
Within dermatology, medications indicated specifically for persistent facial erythema of rosacea primarily consist of topical alpha-adrenergic receptor agonists, notably brimonidine and oxymetazoline.
These agents work by stimulating vascular alpha-adrenergic receptors to induce direct, reversible cutaneous vasoconstriction, thereby temporarily diminishing superficial blood flow and facial redness.
Their therapeutic role is centered specifically on the symptomatic management of persistent centrofacial erythema associated with erythematotelangiectatic and papulopustular rosacea in adults.
-
aafp.org
The phrase "Treatments for Rosacea Erythema" is a clinical indication grouping rather than a formal, single pharmacological drug class
-
fagronacademy.us
The phrase "Treatments for Rosacea Erythema" is a clinical indication grouping rather than a formal, single pharmacological drug class Within dermatology, medications indicated specifically for persistent facial erythema of rosacea primarily consist of topical alpha-adrenergic receptor agonists, notably brimonidine and oxymetazoline These agents work by stimulating vascular alpha-adrenergic receptors to induce direct, reversible cutaneous vasoconstriction, thereby temporarily diminishing superfi...
-
jcadonline.com
Within dermatology, medications indicated specifically for persistent facial erythema of rosacea primarily consist of topical alpha-adrenergic receptor agonists, notably brimonidine and oxymetazoline
-
ahdbonline.com
These agents work by stimulating vascular alpha-adrenergic receptors to induce direct, reversible cutaneous vasoconstriction, thereby temporarily diminishing superficial blood flow and facial redness Their therapeutic role is centered specifically on the symptomatic management of persistent centrofacial erythema associated with erythematotelangiectatic and papulopustular rosacea in adults
-
consultant360.com
Their therapeutic role is centered specifically on the symptomatic management of persistent centrofacial erythema associated with erythematotelangiectatic and papulopustular rosacea in adults
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.